ContraFect Corp (CFRXQ)
0.015
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
ContraFect Shareholders Equity (Quarterly): -5.759M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -5.759M |
| June 30, 2023 | -1.108M |
| March 31, 2023 | -3.137M |
| December 31, 2022 | -11.85M |
| September 30, 2022 | -3.103M |
| June 30, 2022 | 12.88M |
| March 31, 2022 | 30.00M |
| December 31, 2021 | 49.38M |
| September 30, 2021 | 53.00M |
| June 30, 2021 | 57.43M |
| March 31, 2021 | 61.90M |
| December 31, 2020 | 12.62M |
| September 30, 2020 | 18.40M |
| June 30, 2020 | 14.27M |
| March 31, 2020 | 8.608M |
| December 31, 2019 | 15.54M |
| September 30, 2019 | 4.219M |
| June 30, 2019 | 9.188M |
| March 31, 2019 | 17.48M |
| December 31, 2018 | 5.542M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.7014M |
| June 30, 2018 | -7.159M |
| March 31, 2018 | 12.51M |
| December 31, 2017 | 31.19M |
| September 30, 2017 | 35.47M |
| June 30, 2017 | 11.09M |
| March 31, 2017 | 13.55M |
| December 31, 2016 | 19.51M |
| September 30, 2016 | 18.55M |
| June 30, 2016 | 13.77M |
| March 31, 2016 | 22.86M |
| December 31, 2015 | 30.68M |
| September 30, 2015 | 28.17M |
| June 30, 2015 | 33.13M |
| March 31, 2015 | 21.10M |
| December 31, 2014 | 25.58M |
| September 30, 2014 | 29.51M |
| June 30, 2014 | -25.62M |
| March 31, 2014 | 1.071M |
| December 31, 2013 | -13.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.85M
Minimum
Dec 2022
61.90M
Maximum
Mar 2021
17.92M
Average
12.75M
Median
Shareholders Equity (Quarterly) Benchmarks
| Athersys Inc | -36.40M |
| Merck & Co Inc | 40.36B |
| MEI Pharma Inc | 51.03M |
| Bristol-Myers Squibb Co | 16.49B |
| NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.125M |
| Total Liabilities (Quarterly) | 14.88M |